ePrints

Erratum to 'Poly (ADP-ribose) polymerase inhibitors in solid tumours: Systematic review and meta-analysis' [Eur J Cancer 149 (2021) 134–152] (European Journal of Cancer (2021) 149 (134–152), (S095980492100143X), (10.1016/j.ejca.2021.02.035))

Lookup NU author(s): Dr Pasquale RescignoORCiD

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Abstract

© 2021 Elsevier Ltd. The publisher regrets that errors were made regarding the named trial PRIMA in section 4.4. 'Results based on mutational status'. The sentence "Intriguingly, the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) trial in ovarian cancer was able to identify a PFS improvement with niraparib monotherapy in HRR-proficient MOC [31]." should have appeared as follows "Intriguingly, the PRIMA trial in ovarian cancer was able to identify a PFS improvement with niraparib monotherapy in HRR-proficient MOC [31]." The publisher would like to apologise for any inconvenience caused.

Publication metadata

Author(s): Schettini F, Giudici F, Bernocchi O, Sirico M, Corona SP, Giuliano M, Locci M, Paris I, Scambia G, De Placido S, Rescigno P, Prat A, Curigliano G, Generali D

Publication type: Note

Publication status: Published

Journal: European Journal of Cancer

Year: 2021

Volume: 153

Pages: 274-274

Print publication date: 01/08/2021

Online publication date: 25/06/2021

Acceptance date: 02/04/2018

ISSN (print): 0959-8049

ISSN (electronic): 1879-0852

Publisher: Elsevier Ltd

URL: https://doi.org/10.1016/j.ejca.2021.06.001

DOI: 10.1016/j.ejca.2021.06.001

PubMed id: 34176706

Share